BEAM
Price
$23.99
Change
-$0.38 (-1.56%)
Updated
Sep 11 closing price
Capitalization
2.48B
58 days until earnings call
Intraday BUY SELL Signals
FLNA
Price
$0.77
Change
-$0.04 (-4.94%)
Updated
Sep 11 closing price
Capitalization
37.29M
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs FLNA

BEAM vs FLNA Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. FLNA commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and FLNA is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.48B) has a higher market cap than FLNA($37.3M). BEAM YTD gains are higher at: -13.456 vs. FLNA (-60.980). FLNA has higher annual earnings (EBITDA): -45.72M vs. BEAM (-355.78M). BEAM has more cash in the bank: 1.15B vs. FLNA (82.7M). BEAM has higher revenues than FLNA: BEAM (156M) vs FLNA (0).
BEAMFLNABEAM / FLNA
Capitalization2.48B37.3M6,641%
EBITDA-355.78M-45.72M778%
Gain YTD-13.456-60.98022%
P/E RatioN/AN/A-
Revenue156M0-
Total Cash1.15B82.7M1,394%
Total Debt247MN/A-
FUNDAMENTALS RATINGS
BEAM vs FLNA: Fundamental Ratings
BEAM
FLNA
OUTLOOK RATING
1..100
872
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
30
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9298
PRICE GROWTH RATING
1..100
6089
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BEAM's Valuation (24) in the null industry is in the same range as FLNA (30) in the Pharmaceuticals Other industry. This means that BEAM’s stock grew similarly to FLNA’s over the last 12 months.

BEAM's Profit vs Risk Rating (100) in the null industry is in the same range as FLNA (100) in the Pharmaceuticals Other industry. This means that BEAM’s stock grew similarly to FLNA’s over the last 12 months.

BEAM's SMR Rating (92) in the null industry is in the same range as FLNA (98) in the Pharmaceuticals Other industry. This means that BEAM’s stock grew similarly to FLNA’s over the last 12 months.

BEAM's Price Growth Rating (60) in the null industry is in the same range as FLNA (89) in the Pharmaceuticals Other industry. This means that BEAM’s stock grew similarly to FLNA’s over the last 12 months.

BEAM's P/E Growth Rating (100) in the null industry is in the same range as FLNA (100) in the Pharmaceuticals Other industry. This means that BEAM’s stock grew similarly to FLNA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BEAMFLNA
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
86%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (BEAM: $23.99 vs. FLNA: $0.77)
Brand notoriety: BEAM and FLNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 59% vs. FLNA: 105%
Market capitalization -- BEAM: $2.48B vs. FLNA: $37.29M
BEAM [@Biotechnology] is valued at $2.48B. FLNA’s [@Biotechnology] market capitalization is $37.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green while FLNA’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • FLNA’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than FLNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while FLNA’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 5 bearish.
  • FLNA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than FLNA.

Price Growth

BEAM (@Biotechnology) experienced а -19.12% price change this week, while FLNA (@Biotechnology) price change was -5.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 09, 2026.

FLNA is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
BEAM
Daily Signal:
Gain/Loss:
FLNA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLCI3.24N/A
N/A
Mount Logan Capital Inc
BDSAX22.79N/A
N/A
BlackRock Advantage Small Cap Core Inv A
DODEX14.77N/A
N/A
Dodge & Cox Emerging Markets Stock
ELVA6.43-0.16
-2.43%
Electrovaya
WLTH10.38-0.50
-4.60%
Wealthfront Corp.

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-1.56%
CRSP - BEAM
77%
Closely correlated
-1.03%
EDIT - BEAM
66%
Closely correlated
+1.89%
PRME - BEAM
66%
Loosely correlated
-6.57%
NTLA - BEAM
61%
Loosely correlated
-1.59%
RXRX - BEAM
59%
Loosely correlated
+1.27%
More

FLNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, FLNA has been loosely correlated with RXRX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if FLNA jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FLNA
1D Price
Change %
FLNA100%
-4.49%
RXRX - FLNA
43%
Loosely correlated
+1.27%
EDIT - FLNA
42%
Loosely correlated
+1.89%
PRME - FLNA
39%
Loosely correlated
-6.57%
ALT - FLNA
37%
Loosely correlated
-0.61%
BEAM - FLNA
37%
Loosely correlated
-1.56%
More